DDDD - ETF AI Analysis
Top Page
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD)
DDDD, the YieldMax U.S. Stocks Target Double Distribution ETF, has a solid overall rating, suggesting it holds generally strong, well-established companies with supportive cash flows and dividends. High-quality holdings like Merck, Verizon, and Amgen boost the fund’s appeal through robust financial performance, attractive or reasonable valuations, and positive business outlooks, while some positions such as Procter & Gamble and Chevron face weaker technical trends or valuation concerns that slightly temper the rating. A key risk is that several major holdings share challenges like high leverage or potential overvaluation, which could weigh on returns if market conditions worsen.
DDDD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 7.71M
- Region
- North America
- Expense Ratio
- 1.01%
- Beta
- 0.04
- Issuer
- YieldMax
- Inception Date
- Mar 11, 2026
- Dividend Yield
- 1.64%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DDDD Summary
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD) is an income-focused fund that aims to pay higher cash distributions by investing in a broad U.S. dividend ETF and using options on top of it. It follows a high-dividend U.S. stock theme, with exposure to sectors like consumer goods, health care, energy, and technology. Well-known companies indirectly held through its core ETF include Coca-Cola and Procter & Gamble. Investors might consider DDDD if they want diversified U.S. stock exposure with the potential for higher income. A key risk is that the options strategy can limit gains in strong markets and the share price can still go up and down with the market.
How much will it cost me?
This ETF has an expense ratio of 1.01%, which means you’ll pay about $10.10 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and uses a more complex options strategy to try to boost income.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays stable, interest rates fall, and large, established dividend payers in sectors like health care, consumer staples, and energy remain profitable, since that supports both dividend payments and the options income strategy. On the downside, a sharp market rally could see the fund lag because its options approach can cap gains, while rising rates, tighter regulations, or sector-specific problems for key holdings like Texas Instruments, UnitedHealth, or Chevron could pressure both stock prices and the income it can generate.
DDDD Top 10 Holdings
This ETF leans heavily on a broad mix of U.S. dividend stalwarts, with tech, health care, and consumer defensive names doing much of the heavy lifting. Texas Instruments and Qualcomm have been rising, giving the fund a helpful tech tailwind, while Amgen and Merck add steady, health care-driven momentum. On the defensive side, Coca-Cola and Procter & Gamble keep the income stream humming even when markets wobble. Energy giants like Chevron and ConocoPhillips have been more mixed lately, occasionally tugging performance back, but the overall story is diversified, U.S.-centric income with a tech-and-health-care tilt.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PG | Procter & Gamble | 4.45% | $343.22K | $383.36B | 13.19% | 69Neutral |
 HD | Home Depot | 4.31% | $332.44K | $342.68B | -6.94% | 66Neutral |
 TXN | Texas Instruments | 4.28% | $330.16K | $253.44B | 71.87% | 78Outperform |
 KO | Coca-Cola | 4.26% | $328.64K | $411.56B | 38.53% | 75Outperform |
 AMGN | Amgen | 4.09% | $314.83K | $249.05B | 45.89% | 77Outperform |
 ABT | Abbott Laboratories | 4.04% | $311.26K | $190.39B | -12.02% | 73Outperform |
 PEP | PepsiCo | 3.99% | $307.40K | $192.61B | -0.17% | 78Outperform |
 CVX | Chevron | 3.95% | $304.49K | $417.87B | 39.02% | 71Outperform |
 COP | Conocophillips | 3.87% | $298.55K | $161.12B | 59.08% | 78Outperform |
 ACN | Accenture | 3.86% | $297.77K | $153.97B | 7.94% | 79Outperform |
DDDD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DDDD, the sentiment is Neutral. The current price of 34.12 is above the 20-day moving average (MA) of 33.82, above the 50-day MA of 33.08, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.50 indicates Negative momentum. The RSI at 56.95 is Neutral, neither overbought nor oversold. The STOCH value of 51.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DDDD.
DDDD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DDDD | $34.12 | $36.00(5.52% Upside) | $7.71M | 1.01% | 75Outperform |
 PAYR | $56.10 | $60.62(8.06% Upside) | $94.19M | 0.40% | 66Neutral |
 HQDG | $24.78 | $30.94(24.84% Upside) | $73.90M | 0.50% | 73Outperform |
 FDIV | $27.74 | $32.04(15.47% Upside) | $57.85M | 0.35% | 70Neutral |
 DIVY | $31.33 | $34.45(9.95% Upside) | $30.06M | 0.45% | 69Neutral |
 VUS | $28.40 | $35.53(25.10% Upside) | $16.97M | 0.25% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DDDD | YieldMax U.S. Stocks Target Double Distribution ETF | 34.12 | 4.29 | 14.37% | |
| PAYR | Federated Hermes Enhanced Income ETF | 56.10 | 10.08 | 21.91% | |
| HQDG | Raub Brock Dividend Growth ETF | 24.78 | -0.21 | -0.84% | |
| FDIV | MarketDesk Focused U.S. Dividend ETF | 27.74 | 1.92 | 7.45% | |
| DIVY | Sound Equity Income ETF | 31.33 | 6.55 | 26.43% | |
| VUS | Virtus US Dividend ETF | 28.40 | 3.91 | 15.99% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.